C243H161N43O2S — CID 160794072
2,6-bis[3-(9H-carbazol-4-yl)imidazo[4,5-b]pyridin-2-yl]-N,N-diphenylpyridin-4-amine;10-[2,6-bis(3-dibenzofuran-1-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]phenothiazine;10-[2,6-bis(1-phenylbenzimidazol-2-yl)-4-pyridinyl]-21,21-dimethyl-10,14-diazapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene;9-[2,6-bis(1-pyridin-4-ylbenzimidazol-2-yl)-4-pyridinyl]-3,6-dimethylcarbazole;10-[2,6-bis(3-pyridin-4-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]-9,9-dimethylacridine (PubChem CID 160794072) has the molecular formula C243H161N43O2S and a molecular weight of 3747.33 g/mol. Its IUPAC name is 2,6-bis[3-(9H-carbazol-4-yl)imidazo[4,5-b]pyridin-2-yl]-N,N-diphenylpyridin-4-amine;10-[2,6-bis(3-dibenzofuran-1-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]phenothiazine;10-[2,6-bis(1-phenylbenzimidazol-2-yl)-4-pyridinyl]-21,21-dimethyl-10,14-diazapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene;9-[2,6-bis(1-pyridin-4-ylbenzimidazol-2-yl)-4-pyridinyl]-3,6-dimethylcarbazole;10-[2,6-bis(3-pyridin-4-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]-9,9-dimethylacridine.
| Compound Name | 2,6-bis[3-(9H-carbazol-4-yl)imidazo[4,5-b]pyridin-2-yl]-N,N-diphenylpyridin-4-amine;10-[2,6-bis(3-dibenzofuran-1-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]phenothiazine;10-[2,6-bis(1-phenylbenzimidazol-2-yl)-4-pyridinyl]-21,21-dimethyl-10,14-diazapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene;9-[2,6-bis(1-pyridin-4-ylbenzimidazol-2-yl)-4-pyridinyl]-3,6-dimethylcarbazole;10-[2,6-bis(3-pyridin-4-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]-9,9-dimethylacridine |
|---|---|
| PubChem CID | 160794072 |
| Molecular Formula | C243H161N43O2S |
| Molecular Weight | 3747.33 g/mol |
| Exact Mass | 3744.35 |
| IUPAC Name | 2,6-bis[3-(9H-carbazol-4-yl)imidazo[4,5-b]pyridin-2-yl]-N,N-diphenylpyridin-4-amine;10-[2,6-bis(3-dibenzofuran-1-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]phenothiazine;10-[2,6-bis(1-phenylbenzimidazol-2-yl)-4-pyridinyl]-21,21-dimethyl-10,14-diazapentacyclo[11.8.0.03,11.04,9.015,20]henicosa-1(13),2,4,6,8,11,15,17,19-nonaene;9-[2,6-bis(1-pyridin-4-ylbenzimidazol-2-yl)-4-pyridinyl]-3,6-dimethylcarbazole;10-[2,6-bis(3-pyridin-4-ylimidazo[4,5-b]pyridin-2-yl)-4-pyridinyl]-9,9-dimethylacridine |
| SMILES | CC1(C)c2ccccc2N(c2cc(-c3nc4cccnc4n3-c3ccncc3)nc(-c3nc4cccnc4n3-c3ccncc3)c2)c2ccccc21.CC1(C)c2ccccc2Nc2cc3c(cc21)c1ccccc1n3-c1cc(-c2nc3ccccc3n2-c2ccccc2)nc(-c2nc3ccccc3n2-c2ccccc2)c1.Cc1ccc2c(c1)c1cc(C)ccc1n2-c1cc(-c2nc3ccccc3n2-c2ccncc2)nc(-c2nc3ccccc3n2-c2ccncc2)c1.c1ccc(N(c2ccccc2)c2cc(-c3nc4cccnc4n3-c3cccc4[nH]c5ccccc5c34)nc(-c3nc4cccnc4n3-c3cccc4[nH]c5ccccc5c34)c2)cc1.c1ccc2c(c1)Sc1ccccc1N2c1cc(-c2nc3cccnc3n2-c2cccc3oc4ccccc4c23)nc(-c2nc3cccnc3n2-c2cccc3oc4ccccc4c23)c1 |
| InChI | InChI=1S/C53H34N10.C53H30N8O2S.C52H37N7.C43H30N8.C42H30N10/c1-3-15-33(16-4-1)61(34-17-5-2-6-18-34)35-31-44(52-59-42-25-13-29-54-50(42)62(52)46-27-11-23-40-48(46)36-19-7-9-21-38(36)56-40)58-45(32-35)53-60-43-26-14-30-55-51(43)63(53)47-28-12-24-41-49(47)37-20-8-10-22-39(37)57-41;1-5-21-42-32(13-1)48-40(19-9-23-44(48)62-42)60-50-34(15-11-27-54-50)57-52(60)36-29-31(59-38-17-3-7-25-46(38)64-47-26-8-4-18-39(47)59)30-37(56-36)53-58-35-16-12-28-55-51(35)61(53)41-20-10-24-45-49(41)33-14-2-6-22-43(33)63-45;1-52(2)38-22-10-11-23-40(38)53-43-32-49-37(31-39(43)52)36-21-9-14-26-46(36)57(49)35-29-44(50-55-41-24-12-15-27-47(41)58(50)33-17-5-3-6-18-33)54-45(30-35)51-56-42-25-13-16-28-48(42)59(51)34-19-7-4-8-20-34;1-27-11-13-38-32(23-27)33-24-28(2)12-14-39(33)49(38)31-25-36(42-47-34-7-3-5-9-40(34)50(42)29-15-19-44-20-16-29)46-37(26-31)43-48-35-8-4-6-10-41(35)51(43)30-17-21-45-22-18-30;1-42(2)30-9-3-5-13-36(30)50(37-14-6-4-10-31(37)42)29-25-34(40-48-32-11-7-19-45-38(32)51(40)27-15-21-43-22-16-27)47-35(26-29)41-49-33-12-8-20-46-39(33)52(41)28-17-23-44-24-18-28/h1-32,56-57H;1-30H;3-32,53H,1-2H3;3-26H,1-2H3;3-26H,1-2H3 |
| InChIKey | SCEYTCCUATYEMT-UHFFFAOYSA-N |
| XLogP | 57.19 |
| TPSA | 461.02 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 44 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 289 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3747.33 |
| LogP ≤ 5 | 57.19 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 44 |